LawrenceIGolbeMD
Neurology • New Brunswick, NJProfessor of Neurology, UMDNJ-RW Johnson Medical School
Dr. Golbe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 Paterson Street
CAB# 6200
New Brunswick, NJ 08901Phone+1 732-235-7733Fax+1 732-235-7041- Is this information wrong?
Education & Training
NYU Grossman School of MedicineResidency, Neurology, 1980 - 1983
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1978 - 1980- New York University School of MedicineClass of 1978
Certifications & Licensure
NJ State Medical License 1983 - 2023
PA State Medical License 1979 - 1981- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors Castle Connolly, 2003-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Join now to see all
Clinical Trials
- Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Start of enrollment: 2015 Oct 02
Publications & Presentations
PubMed
- Novel avenues of tau research.Claire E Sexton, Gal Bitan, Kathryn R Bowles, Miroslaw Brys, Luc Buée, Mahmoud Bukar Maina, Claire D Clelland, Ann D Cohen, John F Crary, Jeffrey L Dage, Kristophe Dia...> ;Alzheimer's & Dementia. 2024 Mar 1
- Concomitant Medications for Progressive Supranuclear Palsy: A Secondary Analysis of a Randomized Clinical Trial.Iyer, J., Gunzler, D., Lang, A., , Golbe, L., Pantelyat, A., Boxer, A., Wills, A.> ;JAMA Neurology. 2024 Mar 1
- Early, Middle, and Late-Stage Progression Rates in Progressive Supranuclear palsy-Richardson Syndrome.Liao, C., Xie, T., Golbe, L.> ;Movement Disorders Clinical Practice. 2023 Dec 1
- Join now to see all
Press Mentions
Supports the FTD Disorders Registry with $100,000 GrantNovember 12th, 2019- Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody That Targets a Potent Driver of Neurodegenerative DiseaseOctober 31st, 2019
- CurePSP Awards Seven New Research GrantsJuly 29th, 2019
Grant Support
- Glutathione S-Transferase Polymorphisms In Park1 Parkin*National Institute Of Neurological Disorders And Stroke2002–2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
